DY
AGN

Dowling & Yahnke’s Allergan plc AGN Stock Holding History

Dowling & Yahnke’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-2,877
Closed -$510K – 313
2020
Q1 		$510K Buy
2,877
+345
+14% +$65K 0.05% 211
2019
Q4 		$484K Buy
2,532
+304
+14% +$54.8K 0.04% 238
2019
Q3 		$375K Buy
2,228
+984
+79% +$160K 0.03% 248
2019
Q2 		$208K Sell
1,244
-905
-42% -$125K 0.02% 284
2019
Q1 		$315K Buy
2,149
+401
+23% +$58.1K 0.03% 227
2018
Q4 		$274K Sell
1,748
-345
-16% -$56.6K 0.03% 225
2018
Q3 		$399K Buy
2,093
+330
+19% +$60.6K 0.03% 239
2018
Q2 		$294K Buy
+1,763
New +$283K 0.03% 247
2018
Q1 		– Sell
-1,253
Closed -$205K – 295
2017
Q4 		$205K Buy
+1,253
New +$225K 0.02% 286
2015
Q2 		– Sell
-1,631
Closed -$485K – 268
2015
Q1 		$485K Buy
1,631
+668
+69% +$190K 0.06% 197
2014
Q4 		$248K Buy
963
+14
+1% +$3.5K 0.03% 237
2014
Q3 		$229K Hold
949
– – 0.03% 235
2014
Q2 		$212K Buy
+949
New +$196K 0.03% 257

Other funds holding AGN

AJ
Ashburton (Jersey) St Helier, Jersey $227M AUM
C
Cerebellum San Francisco, California $21.5M AUM
B
Barings Charlotte, North Carolina $6.19B AUM 16.5% 1-Year Est. Return
JJ
JDC-JSC New York $20.8M AUM 30.94% 1-Year Est. Return
VFA
Valeo Financial Advisors Carmel, Indiana $4.74B AUM 27.69% 1-Year Est. Return
OPS
Orion Portfolio Solutions Omaha, Nebraska $10.2B AUM 6.73% 1-Year Est. Return

Dowling & Yahnke's AGN Position: Q2 2020 in Review

Dowling & Yahnke sold out of Allergan plc (AGN) in Q2 2020, closing a stake of 2,877 shares — an estimated $510K sold.

Dowling & Yahnke first reported a position in AGN in Q2 2014 and held it in 13 quarters. The position peaked at $510K in Q1 2020. 7 funds tracked by Wall St. Rank hold AGN as of Q2 2020.

  • Dowling & Yahnke reported no remaining Allergan plc position as of Q2 2020 after selling out during the quarter.
  • Dowling & Yahnke sold 2,877 Allergan plc shares in Q2 2020, an estimated $510K.
  • Dowling & Yahnke first reported a position in Allergan plc in Q2 2014 and held it in 13 quarters.
  • Dowling & Yahnke's Allergan plc position peaked at $510K in Q1 2020.
  • 7 funds tracked by Wall St. Rank held Allergan plc as of Q2 2020.

Based on Dowling & Yahnke's 13F filing for Q2 2020, filed 31 Jul 2020.